Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Gastroenterology
|
April 3, 2026
Response to Letters Regarding "Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma"
Aimee L Lucas, Randall E Brand, Norma A Palma
Diagnostics (Basel, Switzerland)
|
December 30, 2025
Analytical Validation of a Serum Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma
Robyn Pescatore, Naphtali Milliken, Thomas King, et al.
Journal of Proteome Research
|
December 19, 2024
Biomarker Discovery for Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) Using Multiplex Proteomics Technology
Alcibiade Athanasiou, Natasha Kureshi, Anja Wittig, et al.
Current Oncology (Toronto, Ont.)
|
November 26, 2025
Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma
Patricio M Polanco, Tamas Gonda, Erkut Borazanci, et al.
Cancers
|
June 13, 2025
A High Performing Biomarker Signature for Detecting Early-Stage Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
Norma A Palma, Aimee L Lucas, Bryson W Katona, et al.
Case Reports in Oncology
|
November 20, 2014
A Poorly Differentiated Malignant Neoplasm Lacking Lung Markers Harbors an EML4-ALK Rearrangement and Responds to Crizotinib
Jon H Chung, Siraj M Ali, Jenni Davis, et al.
Breast Cancer Research and Treatment
|
October 14, 2015
Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations
Jeffrey S Ross, Siraj M Ali, Kai Wang, et al.
Case Reports in Oncology
|
September 19, 2014
Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary
Norma A Palma, Siraj M Ali, Jamie O'Connor, et al.
The Oncologist
|
April 18, 2015
Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies
Siraj M Ali, Eric M Sanford, Samuel J Klempner, et al.
The Oncologist
|
December 17, 2015
Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations
Siraj M Ali, Sumanta K Pal, Kai Wang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Gastroenterology
|
April 3, 2026
Response to Letters Regarding "Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma"
Aimee L Lucas, Randall E Brand, Norma A Palma
Diagnostics (Basel, Switzerland)
|
December 30, 2025
Analytical Validation of a Serum Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma
Robyn Pescatore, Naphtali Milliken, Thomas King, et al.
Journal of Proteome Research
|
December 19, 2024
Biomarker Discovery for Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) Using Multiplex Proteomics Technology
Alcibiade Athanasiou, Natasha Kureshi, Anja Wittig, et al.
Current Oncology (Toronto, Ont.)
|
November 26, 2025
Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma
Patricio M Polanco, Tamas Gonda, Erkut Borazanci, et al.
Cancers
|
June 13, 2025
A High Performing Biomarker Signature for Detecting Early-Stage Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
Norma A Palma, Aimee L Lucas, Bryson W Katona, et al.
Case Reports in Oncology
|
November 20, 2014
A Poorly Differentiated Malignant Neoplasm Lacking Lung Markers Harbors an EML4-ALK Rearrangement and Responds to Crizotinib
Jon H Chung, Siraj M Ali, Jenni Davis, et al.
Breast Cancer Research and Treatment
|
October 14, 2015
Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations
Jeffrey S Ross, Siraj M Ali, Kai Wang, et al.
Case Reports in Oncology
|
September 19, 2014
Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary
Norma A Palma, Siraj M Ali, Jamie O'Connor, et al.
The Oncologist
|
April 18, 2015
Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies
Siraj M Ali, Eric M Sanford, Samuel J Klempner, et al.
The Oncologist
|
December 17, 2015
Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations
Siraj M Ali, Sumanta K Pal, Kai Wang, et al.
Page
of 2